Table 1.
Virus | T Cell Type/Phenotype | Disease Condition | Markers | Gene Regulation | Function | References |
---|---|---|---|---|---|---|
CHIKV | CD8+ T cells | Acute | Upregulation | T cell activation, destroy virus infected cells | [32,34,35,36] | |
Acute | IL-17, IL-10 R | Downregulation | develop joint symptoms in acute phase and maintain these symptoms in the chronic phase | [35] | ||
Chronic | CD95L | Upregulation | involved in CHIKV chronicity mechanism | [35] | ||
CD4+ T cells | Acute | CD95L | Upregulation | apoptosis of CD4 T cells | [32] | |
Chronic | , | Upregulation | inflammation and joint swelling | [39] | ||
T cells | Acute | Downregulation | reduced foot swelling in mice | [45,46,109] | ||
CD4-Treg | recovery | IL-10 | Up regulation | resolution of the disease | [48] | |
DENV | CD8+ T cells | Acute | CCR5, CXCR3, CXCR6 | Upregulation | supporting T cells to migrate in to peripheral inflamed tissues | [53,54] |
CLA | Upregulation | influx of T cells to skin providing immediate onsite protection | [117] | |||
CD69, HLA-DP, DQ, DR, CD38, cytotoxic granule TIA-1, VLA-4, ICAM-1, LFA-1CD44, CD11a | Upregulation | T cell activation, elimination the virus, induce inflammation | [117] | |||
HLA-DR+CD38+ CD8+T cells | Acute | PD-1, Lag3, KLRG1, CTLA-4, CD160 | Upregulation | T cell activation, Proliferation, cytotoxicity and migration | [72] | |
HLA-DR−CD38+ CD8+ T cells | Acute | AKT3, ACTN1 | Downregulation | TCR signaling, amplification and synapse | [72] | |
CD8+Tem (CD45RA−CCR7−) and Temra (CD45RA+CCR7−) | Acute | , TNFα, CTLA4, ICOS, LIGHT, IRF4, IRF8, SLAMF7, KIR2DL3 | Upregulation | T cell activation, proliferation and polyfunctional properties, narrow transcriptional responses | [73] | |
CXCR5+CD8+ T cells (TFH) | Chronic | PD-1 | Upregulation | T cell proliferation and exert effector functions | [74] | |
CD4+ T cells | Upregulation | cytotoxic effects | [77,79] | |||
CD4+Temra CD45RA+CCR7− | Upregulation | cytotoxic, protective role in DENV with HLA DR allele | [81] | |||
CD4+CD25+FoxP3+ Treg | acute | CTLA-4 | Upregulation | producing immunosuppressive cytokines | [82,83] | |
TFH | critical | CD40L | Upregulation | strong activator of B cells | [86,87] | |
TFHCXCR5+CD45RA−CD4+Tcells | Critical | PD-1, CD38 | Upregulation | predictor for neutralizing antibody titer and disease severity | [85] | |
ZIKV | CD8+IFN-γ+ T cells | acute | granzyme B, CRTAM, X-C motif chemokine ligand 1 and 2, CC3, CC4 |
Upregulation | cytotoxicity, T cell activation and regulation, proinflammation, T cell homing | [101] |
CD8+IFN-γ+ T cells | Acute | , TNF-α, Granzyme B | Upregulation | Th1, Th2, Th17 and Th9 responses | [17,102] | |
2 T cells | Acute | Granzyme B | Upregulation | antiviral and stimulatory activities | [115,116] |